Remove Clinical Trials Remove Pets Remove State Laws
article thumbnail

Weekly Legislative Roundup 1/18/19

NORML

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Additionally, a bipartisan coalition of U.S.

article thumbnail

MAPS – Position: State Government Affairs Lead – Remote

Cannabis Law Report

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. Pet Insurance. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

Other CBD products, however, are still subject to various state law regulations as well as the U.S. The FDA specifically found that Curaleaf marketed its CBD products online with unsubstantiated claims that they treated (among other things) cancer, opioid withdrawal, pain and pet anxiety, and Alzheimer’s disease.

CBD 80
article thumbnail

FDA CBD Regulations Are On the Way (Sorta)

Canna Law Blog

With the passage of the 2014 Farm Bill , CBD derived from hemp — if cultivated pursuant to a state research pilot program — got a little bit of precarious legal cover. And marketing any bodily or curative effects of CBD was (and still is) off limits. 2018 Farm Bill.

CBD 98